UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 6, 2017

Accession Number:	0000950123-17-005570
Submission Type:	POS AM
CIK: 0001566373 Company Name: Spring Bank Pharmaceuticals, Inc. File Number: 333-215122